Cargando…
Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
Medication overuse headache (MOH) places both a physical and emotional burden on patients. MOH may occur as a consequence of a negative spiral of events comprising an increasing number of headache days while taking frequent or excessive amounts of medications for acute treatment of headaches or migr...
Autor principal: | Limberg, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444718/ https://www.ncbi.nlm.nih.gov/pubmed/37347339 http://dx.doi.org/10.1007/s40122-023-00534-w |
Ejemplares similares
-
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021) -
A Review of Eptinezumab Use in Migraine
por: Datta, Abhigyan, et al.
Publicado: (2021) -
Eptinezumab for migraine
Publicado: (2022) -
Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016) -
Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
por: Bader, Yazan, et al.
Publicado: (2023)